OncoBark launches breakthrough OncoGx16 cancer test

Early detection provides opportunity for early intervention

Spot the signs of canine cancer before symptoms appear

Dogs are not our whole life, but they make our lives whole.

—Roger Caras

BOSTON, MASSACHUSETTS, UNITED STATES, June 29, 2022 /EINPresswire.com/ — OncoBark unveils the world’s first canine cancer detection kit, OncoGx16 Cancer Test, which can detect 16 specific types of canine cancer at an early stage with unprecedented precision.

Most accurate point-of-care canine cancer screening test

Many pet owners go above and beyond to prioritize their dogs’ well-being over their own. Yet, finding effective and preventative ways to take care of canine health is difficult, especially when it comes to cancer, which unfortunately is on the rise with around 6 million dogs being diagnosed each year.

However, good news awaits you!

Oncobark provides dog owners with a powerful new tool to monitor their pet’s health. The Canine OncoGx16 Cancer test uses breakthrough DNA technology to accurately determine oncological conditions in dogs before any signs of cancer appear, and this simple, non-invasive nasal swab allows pet owners to be proactive about their health. of their dog.

Early detection provides opportunity for early intervention
The Oncobark team is made up of expert scientists with over 40 years of experience in cutting-edge molecular technology. As dog owners themselves, OncoBark scientists are passionate about implementing better solutions for the diagnosis and monitoring of canine cancer.

The OncoGx16 Cancer Kit has undergone years of rigorous testing and research. Yet for dog owners and their dogs, this test is remarkably simple and accurate! It uses traces of DNA in the nasal secretions of dogs to detect the presence of early-stage cancers that can be present anywhere in the dog’s body. This needle-free DNA sample can detect 16 specific types of cancer, including the 7 most common canine cancers before clinical signs are noticeable. Stage 0 detection allows pet owners to consult with their veterinarians to determine the best approach to support their pet’s longevity.

Now available on OncoBark Online
Priced at $49.99 per test, the OncoGx16 test is affordable and worth every penny compared to late-stage cancer treatments for dogs that average over $10,000; not to mention the intense emotional stress on pets and pet parents while waiting for those lab results. On the other hand, OncoGx16 test results are obtained in minutes and in the comfort of your own home.

As for accuracy, the test has a sensitivity of 98% and a specificity reaching 99.5% based on a clinical study of validated cohorts including hundreds of dogs, with and without diagnosis of cancer for the 16 types of cancers target canines.

“I am excited about the power of this new technology that can be harnessed for routine home cancer screening.” said Dr. CN Wang, Chairman of Kinstagen Corp. “I think OncoGx16 is a quick tool that helps pet parents keep canine family members healthy.” Dr. Wang continued, “In the worst-case scenario, pet parents can be alerted early to allow intervention before their canine children become too ill for veterinarians to attend to.”

“Dogs are not our whole life, but they make our lives whole.” Roger Caras once said. The truth of this adage echoes our feelings! With the OncoGx16 cancer screening test, pet owners can now improve the lives of their children.

The FREE OncoGx16 Kit is available online to all eligible Canine Members over the age of 9, while supplies last, July 1 through September 30, 2022.

For more information, quotes or interview requests, please contact Alice Chow, Media Relations at [email protected]
# # #

ALICE CHOW
ONCOBARK, LLC.
[email protected]

Comments are closed.